Omega 3 fatty acid for the prevention of dementia

被引:91
作者
Lim, WS [1 ]
Gammack, JK [1 ]
Van Niekerk, J [1 ]
Dangour, AD [1 ]
机构
[1] Tan Tock Seng Hosp, Dept Geriatr Med, Singapore 308433, Singapore
来源
COCHRANE DATABASE OF SYSTEMATIC REVIEWS | 2006年 / 01期
关键词
D O I
10.1002/14651858.CD005379.pub2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Accruing evidence from observational and epidemiological studies suggests an inverse relationship between dietary intake of omega 3 polyunsaturated fatty acid (PUFA) and risk of dementia. Postulated mechanisms that might qualify omega 3 PUFA as an interventional target for the primary prevention of dementia include its anti-atherogenic, anti-inflammatory, anti-oxidant, anti-amyloid and neuroprotective properties. Objectives To review the evidence that omega 3 PUFA supplementation prevents cognitive impairment and dementia in cognitively intact elderly persons. Search strategy The Cochrane Dementia and Cognitive Improvement Group's (CDCIG) Specialized register, MEDLINE, EMBASE, CINAHL PsycINFO, AMED AND CENTRAL and several ongoing trials databases were searched on 5 and 6 October 2005. The CDCIG Register is updated regularly and contains records from all major medical databases and many ongoing trials databases. Selection criteria In order to be selected, trials needed to be randomized, placebo-controlled, doubled blinded, of minimum study duration of 6 months, involved persons aged 60 years and above without pre-existing dementia at study onset, and employed cognitive endpoints. Data collection and analysis Reviewers, working independently, were to select, quality assess and extract relevant data where appropriate and possible. In comparing intervention with placebo, the pooled odds ratios or weighted mean differences and standardized mean difference were to be estimated. Main results There were no randomized trials found in the search that met the selection criteria. Results of two clinical trials are expected in 2008. Authors' conclusions There is a growing body of evidence from biological, observational and epidemiological studies that suggests a protective effect of omega 3 PUFA against dementia. However, until data from randomized trials become available for analysis, there is no good evidence to support the use of dietary or supplemental omega 3 PUFA for the prevention of cognitive impairment or dementia.
引用
收藏
页数:13
相关论文
共 56 条
[1]   Inflammation and Alzheimer's disease [J].
Akiyama, H ;
Barger, S ;
Barnum, S ;
Bradt, B ;
Bauer, J ;
Cole, GM ;
Cooper, NR ;
Eikelenboom, P ;
Emmerling, M ;
Fiebich, BL ;
Finch, CE ;
Frautschy, S ;
Griffin, WST ;
Hampel, H ;
Hull, M ;
Landreth, G ;
Lue, LF ;
Mrak, R ;
Mackenzie, IR ;
McGeer, PL ;
O'Banion, MK ;
Pachter, J ;
Pasinetti, G ;
Plata-Salaman, C ;
Rogers, J ;
Rydel, R ;
Shen, Y ;
Streit, W ;
Strohmeyer, R ;
Tooyoma, I ;
Van Muiswinkel, FL ;
Veerhuis, R ;
Walker, D ;
Webster, S ;
Wegrzyniak, B ;
Wenk, G ;
Wyss-Coray, T .
NEUROBIOLOGY OF AGING, 2000, 21 (03) :383-421
[2]  
Alderson P., 2004, COCHRANE REV HDB 4 2
[3]   PLASMA LIPID AND LIPOPROTEIN PATTERN IN GREENLANDIC WEST-COAST ESKIMOS [J].
BANG, HO ;
DYERBERG, J ;
NIELSON, AB .
LANCET, 1971, 1 (7710) :1143-&
[4]   Fish, meat, and risk of dementia:: cohort study [J].
Barberger-Gateau, P ;
Letenneur, L ;
Deschamps, V ;
Pérès, K ;
Dartigues, JF ;
Renaud, S .
BRITISH MEDICAL JOURNAL, 2002, 325 (7370) :932-+
[5]   AN INVENTORY FOR MEASURING DEPRESSION [J].
BECK, AT ;
ERBAUGH, J ;
WARD, CH ;
MOCK, J ;
MENDELSOHN, M .
ARCHIVES OF GENERAL PSYCHIATRY, 1961, 4 (06) :561-&
[6]   The efficacy of 2 different dosages of methylphenidate in treating adults with attention-deficit hyperactivity disorder [J].
Bouffard, R ;
Hechtman, L ;
Minde, K ;
Iaboni-Kassab, F .
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2003, 48 (08) :546-554
[7]   Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model [J].
Calon, F ;
Lim, GP ;
Yang, FS ;
Morihara, T ;
Teter, B ;
Ubeda, O ;
Rostaing, P ;
Triller, A ;
Salem, N ;
Ashe, KH ;
Frautschy, SA ;
Cole, GM .
NEURON, 2004, 43 (05) :633-645
[8]   Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment [J].
Conquer, JA ;
Tierney, MC ;
Zecevic, J ;
Bettger, WJ ;
Fisher, RH .
LIPIDS, 2000, 35 (12) :1305-1312
[9]  
CUMMINGS JL, 2004, NEW ENGL J MED, V35, P156
[10]  
DANGOUR, 2004, OLDER PEOPLE N 3 LON